Work

Abstract 3706: Identifying first-in-class targets for anti-cancer therapy in KRAS mutant NSCLC using the systems biology-based drug discovery platform

Year: 2025
Type: conference-abstract
Language: English
Open Access status: closed
OpenAlex ID: W4409624648
Cites:
Cited by:
Related to: 10